Current Evidence and Treatment Approaches in First-Line Metastatic Triple-Negative Breast Cancer

A panelist discusses recent updates in the first-line treatment of metastatic triple-negative breast cancer, including new clinical trial data, emerging therapies, and the role of biomarker-guided selection in community oncology practice.